Clinical Trials Directory

Trials / Completed

CompletedNCT02548845

An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain

An Observational, Retrospective Study to Describe the Extent of Adherence to the Spanish Society of Medical Oncology Algorithm for the Treatment of Hyponatraemia Secondary to SIADH in Oncology Patients in Spain (ALGA)

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Otsuka Pharmaceutical Europe Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In 2014, the Spanish Sociedad Española de Oncología Médica (SEOM) algorithm for the treatment of hyponatraemia secondary to to syndrome of inappropriate antidiuretic hormone (SIADH) in oncology patients was developed. Since it is hypothesised that the adherence to the SEOM algorithm is not 100%, the current retrospective non-interventional study will investigate the perceived and actual adherence of participating centres to the SEOM algorithm and its impact on patient outcomes

Conditions

Timeline

Start date
2015-12-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2015-09-14
Last updated
2018-08-06
Results posted
2018-08-06

Locations

4 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02548845. Inclusion in this directory is not an endorsement.